SMART
Currently running
Treg-sparing co-stimulation blockade: testing a novel method for monitoring an immunosuppression strategy in people with Type 1 diabetes.
Recruiting sites:
- Cardiff & Vale NHS/Cardiff University
- Royal Free Hospital/University College London
Summary:
We are looking for people aged 18-50 who were diagnosed with Type 1 diabetes in the last 5 years to take part in a study of the immune system responsible for destruction of insulin producing cells. We hope that this will help develop future treatments for Type 1 diabetes.
The study will include administration of drugs and giving blood and lymph node samples.
Aim
This is a study of the immune system responsible for destruction of insulin producing cells. We hope that this will help develop future treatments for Type 1 diabetes.
Eligibility to take part
- Age 18-50 years
- Diagnosed with type 1 diabetes in the last 5 years
If you are interested in taking part, please click the “Get Involved” button below:
What will I be asked to do?
The study will include administration of drugs and giving blood and lymph node samples.
Who is running this study?
This study is sponsored by Cardiff University. It is funded by Steve Morgan Foundation through Grand Challenge award with Breakthrough T1D and Diabetes UK.
